Merck & Co.

Blue race track
Favicon Fierce Pharma

Merck grows more ambitious about 'workhorse' TROP2 ADC

Merck has already registered 15 global phase 3 trials for its Kelun-partnered TROP2 antibody-drug conjugate, sac-TMT.
Angus Liuu Oct 20, 2025 4:00pm
An arrow incrementally going up stairs before pointing straight up Blue background

ESMO: Daiichi, Merck move ovarian cancer ADC toward pivotal test

Oct 20, 2025 10:45am
vials vaccine research vaccines factory manufacturing

Evaxion stock slips on phase 2 cancer vax data

Oct 17, 2025 2:07pm
cardboard box with office belongings and a desk chair

Big pharma cuts and gene therapy woes: Inside Q3's layoffs

Oct 3, 2025 4:30pm
research deal two people shaking hands in lab

Merck opts in on Evaxian's preclinical vaccine candidate

Sep 25, 2025 7:00am
3D Rendering futuristic robot technology development artificial intelligence

Merck inks $349M biobucks deal to apply AI to tricky targets

Sep 23, 2025 7:00am